Serfac

Serfac

citicoline

Manufacturer:

Abbott Products

Marketer:

Abbott Products
Full Prescribing Info
Contents
Citicoline.
Action
Citicoline activates the biosynthesis of phospholipid structures in nerve membranes, increases cerebral metabolism, increases the concentration of various neurotransmitters including acetylcholine and dopamine, shows neuroprotective activity in conditions of hypoxia and ischemia, and improves EEG in a state of loss of consciousness.
In addition, Citicoline inhibits the development of apopleptic stroke and neurological symptoms, increases brain stem blood flow and improves central motor function in patients with cerebrovascular disorders.
Citicoline shows improvement in cerebral function by increasing glucose uptake from the brain inhibiting the accumulation of lactic acid in the brain.
In the case of cerebral ischemia, Citicoline works in conjunction with nerve cell membrane fraction and accelerates biosynthesis of lecithin metabolism.
Indications/Uses
Loss of consciousness due to head injuries or brain surgery. Accelerate rehabilitation in upper extremity in patients with post-apoplectic hemiplegia.
Dosage/Direction for Use
Disturbances of consciousness due to head injuries or brain surgery: Adult: 100-500 mg, once to twice daily by IV infusion or IV/IM injection. The dose can be adjusted to patient's conditions.
Post-apoplectic hemiplegia: 1000 mg once daily by IV 4 weeks consecutively; or 250 mg once daily by IV 4 weeks consecutively, if the signs of improvement shown, the administration may be continued for up to 4 weeks.
Contraindications
Hypersensitivity to Citicoline.
Special Precautions
For patients with acute, severe and progressive disturbances of consciousness due to head injury and brain surgery, Citicoline injection should be administered in conjunction with hemostatics and intracranial pressure relieving drugs, while maintaining body temperature at low levels. In patients with consciousness disturbance of acute cerebral infarction, administration of citicoline should be started within 2 weeks after apoplectic stroke.
Adverse Reactions
If shock symptoms occur such as drastic blood pressure reduction, chest pain and dyspnea, the administration of citicoline should be stopped.
Other side effects that are rarely reported include rash, insomnia, headache, dizziness, excitation, convulsions, numbness, nausea, anorexia, liver dysfunction, transient diplopia, warm sensations, transient changes in blood pressure and malaise.
Storage
Store in the temperature below 30°C, protected from light.
ATC Classification
N06BX06 - citicoline ; Belongs to the class of other psychostimulants and nootropics.
Presentation/Packing
Inj (amp) 250 mg/2 mL x 5's. 500 mg/4 mL x 5's. 1,000 mg/8 mL x 5's.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in